EBRANTIL

This brand name is authorized in Austria, Germany, Croatia, Japan, Poland, Turkey

Active ingredients

The drug EBRANTIL contains one active pharmaceutical ingredient (API):

1 Urapidil UNII A78GF17HJS - URAPIDIL

Urapidil is a α1-adrenoceptor antagonist and 5-HT1A receptor agonist and consequently inhibits the vasoconstrictor effect of catecholamines. It interacts with peripheral α1-adrenoceptors and central 5-HT1A receptors to produce vasodilation without sympathetic activation. Read about Urapidil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02CA06	Urapidil	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00211725, 00212759, 01043603, 01344486, 01344492, 01881356, 01882611, 02192908, 03207948, 03207954, 03207983, 03208008, 03209404, 03209410, 04174091, 05556357, 06064604, 06339403, 06683460, 07745252, 07745269, 09780146, 09780152, 09780169, 09780181
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149020N1031, 2149020N2038
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100021016, 100254163
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699456790171, 8699456790188